Amiodarone attenuates cardiac Rubidium-82 in consecutive PET/CT scans in a rodent model.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
12 2022
Historique:
received: 30 05 2021
accepted: 23 07 2021
pubmed: 7 10 2021
medline: 14 1 2023
entrez: 6 10 2021
Statut: ppublish

Résumé

Risk stratification and diagnosis using Rubidium-82 ( Seventy-seven Sprague-Dawley rats were included in the cross-sectional study. All rats underwent baseline In the control group without pharmacological treatment, no difference in the standard uptake value (SUV) ratio between heart and muscle from baseline to follow-up (5.8 vs 7.0, P = .3) was found. The group treated with amiodarone had a significantly reduced SUV ratio from baseline to follow-up (5.8 vs 5.1, P = .008). All other drugs investigated had no difference in SUV ratio from baseline to follow-up. In this study, we showed that drugs normally used to treat CAD do not affect the uptake of

Sections du résumé

BACKGROUND
Risk stratification and diagnosis using Rubidium-82 (
METHODS
Seventy-seven Sprague-Dawley rats were included in the cross-sectional study. All rats underwent baseline
RESULTS
In the control group without pharmacological treatment, no difference in the standard uptake value (SUV) ratio between heart and muscle from baseline to follow-up (5.8 vs 7.0, P = .3) was found. The group treated with amiodarone had a significantly reduced SUV ratio from baseline to follow-up (5.8 vs 5.1, P = .008). All other drugs investigated had no difference in SUV ratio from baseline to follow-up.
CONCLUSION
In this study, we showed that drugs normally used to treat CAD do not affect the uptake of

Identifiants

pubmed: 34611850
doi: 10.1007/s12350-021-02785-6
pii: 10.1007/s12350-021-02785-6
doi:

Substances chimiques

Rubidium-82 9K730EL8KU
Atorvastatin A0JWA85V8F
Clopidogrel A74586SNO7
Ticagrelor GLH0314RVC
Rubidium Radioisotopes 0
Amlodipine 1J444QC288

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2853-2862

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. American Society of Nuclear Cardiology.

Références

Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P et al (2018) Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Cardiol 25:269-97
doi: 10.1007/s12350-017-1110-x
Juneau D, Erthal F, Ohira H, Mc Ardle B, Hessian R, deKemp RA et al (2016) Clinical PET myocardial perfusion imaging and flow quantification. Cardiol Clin 34:69-85
doi: 10.1016/j.ccl.2015.07.013
Yoshinaga K, Klein R, Tamaki N (2010) Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-from basic aspects to clinical applications Contents. J Cardiol 55:163-73
doi: 10.1016/j.jjcc.2010.01.001
Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF (2007) Diagnostic accuracy of Rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 49:1052-8
doi: 10.1016/j.jacc.2006.12.015
Esteves FP, Sanyal R, Nye JA, Santana CA, Verdes L, Raggi P (2008) Adenosine stress rubidium-82 PET/computed tomography in patients with known and suspected coronary artery disease. Nucl Med Commun 29:674-8
doi: 10.1097/MNM.0b013e328301a614
Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy P, Carlos RC (2008) Diagnostic performance of positron emission tomography in the detection of coronary artery disease. A meta-analysis. Acad Radiol 15:444-51
doi: 10.1016/j.acra.2007.08.012
Mullani NA, Gould KL (1983) First-pass measurements of regional blood flow with external detectors. J Nucl Med 24:577-81
Klocke FJ (1976) Coronary blood flow in man. Prog Cardiovasc Dis 19:117-66
doi: 10.1016/0033-0620(76)90020-7
Kohlhardt M, Fichtner H (1988) Block of single cardiac Na+ channels by antiarrhythmic drugs: The effect of amiodarone, propafenone and diprafenone. J Membr Biol 102:105-19
doi: 10.1007/BF01870449
Haworth RA, Goknur AB, Berkoff HA (1989) Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs. Circ Res 65:1157-60
doi: 10.1161/01.RES.65.4.1157
Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R et al (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407-77
doi: 10.1093/eurheartj/ehz425
Marraffa JM. Amiodarone. In: Encyclopedia of Toxicology. 2014; 197-9.
Bergman M, Cohen F, Schlesinger H, Kessler-Icekson G (1995) Effects of amiodarone on beating rate and Na-K-ATPase activity in cultured neonatal rat heart myocytes. Gen Pharmacol 26:285-90
doi: 10.1016/0306-3623(94)00178-P
Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005; 32: 855-97.
Kinahan PE, Fletcher JW (2010) Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MRI. 31:496-505
doi: 10.1053/j.sult.2010.10.001
Hedrich HJ. Chapter 1 - History, Strains and Models. In: The Laboratory Rat. 2000; 3-16.
Liu L, Wu J, Kennedy DJ (2016) Regulation of cardiac remodeling by cardiac Na+/K+-ATPase isoforms. Front Physiol 7:382
doi: 10.3389/fphys.2016.00382
Zahler R, Sun W, Ardito T, Zhang ZT, Kocsis JD, Kashgarian M (1996) The α3 isoform protein of the Na+, K+-ATPase is associated with the sites of cardiac and neuromuscular impulse transmission. Circ Res 78:870-9
doi: 10.1161/01.RES.78.5.870
Hoffmeister C, Preuss R, Weise R, Burchert W, Lindner O (2014) The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging. J Nucl Cardiol 21:1223-9
doi: 10.1007/s12350-014-9952-y
Bridges AB, Kennedy N, McNeill GP, Cook B, Pringle TH (1992) The effect of atenolol on dipyridamole201T1 myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun 13:41-6
doi: 10.1097/00006231-199201000-00007
Sharir T, Rabinowitz B, Livschitz S, Moalem I, Baron J, Kaplinsky E et al (1998) Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 31:1540-6
doi: 10.1016/S0735-1097(98)00142-9
Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol. 200 ;42:1475-83.
Bøttcher M, Refsgaard J, Madsen MM, Randsbæk F, Kaltoft A, Bøtker HE et al (2003) Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 10:345-52
doi: 10.1016/S1071-3581(03)00454-9
Reyes E, Stirrup J, Roughton M, D’souza S, Underwood SR, Anagnostopoulos C. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective β-adrenoceptor blockers: a crossover myocardial perfusion imaging study. J Nucl Med. 2010;51:1036-43.
Kodama I, Kamiya K, Toyama J (1997) Cellular electropharmacology of amiodarone. Cardiovasc Res 35:13-29
doi: 10.1016/S0008-6363(97)00114-4
Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med. 1990;8:25.
Schmidt KC, Turkheimer FE (2002) Kinetic modeling in positron emission tomography. Q J Nucl Med 46:70-85
Maddahi J, Packard RRS. Cardiac PET perfusion tracers: Current status and future directions. Semin Nucl Med 2014; 44: 333-43.
Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M et al (2011) Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 4:435-43
doi: 10.1161/CIRCIMAGING.110.962126
Morth JP, Pedersen BP, Toustrup-Jensen MS, Sørensen TLM, Petersen J, Andersen JP et al (2007) Crystal structure of the sodium-potassium pump. Nature 450:1043-49
doi: 10.1038/nature06419
Cal-González J, Herraiz JL, España S, Corzo PMG, Vaquero JJ, Desco M et al (2013) Positron range estimations with PeneloPET. Phys Med Biol 58:5127-52
doi: 10.1088/0031-9155/58/15/5127
Jiang L-Q, Chen S-J, Xu J-J, Ran Z, Ying W, Zhao S-G (2016) Dronedarone and amiodarone induce dyslipidemia and thyroid dysfunction in rats. Cell Physiol Biochem 38:2311-22
doi: 10.1159/000445585
Fu Y, Wang Z, Chen WL, Moore PK, Zhu YZ (2007) Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats. AmJPhysiol Hear CircPhysiol. 293:H1545-52
doi: 10.1152/ajpheart.00064.2007
Gupta U, Cook JC, Tassinari MS, Hurtt ME (2003) Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms. Birth Defects Res Part B 68:27-37
doi: 10.1002/bdrb.10007
Mohamed AR, El-Hadidy WF, Mannaa HF (2014) Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. Drugs R D. 14:233-9
doi: 10.1007/s40268-014-0059-3
Grzesk G, Kozinski M, Navarese EP, Krzyzanowski M, Grzesk E, Kubica A et al (2012) Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: a placebo-controlled study in rats. Thromb Res 130:65-9
doi: 10.1016/j.thromres.2011.12.029
Lin L-L, Wang D, Wang W, Cheng Y-Q, Su D-F, Liu A-J (2015) Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats. PLoS ONE 10:e0116155
doi: 10.1371/journal.pone.0116155
Zhou Y, Xu M, Zhang Y, Guo Y, Zhang Y, He B (2014) Effects of long-term application of metoprolol and propranolol in a rat model of smoking. Clin Exp Pharmacol Physiol 41:708-15

Auteurs

Simon Bentsen (S)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark.
Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Lia E Bang (LE)

Department of Cardiology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.

Philip Hasbak (P)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark.

Andreas Kjaer (A)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark. akjaer@sund.ku.dk.
Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. akjaer@sund.ku.dk.

Rasmus S Ripa (RS)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark.
Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

Humans United States Aged Cross-Sectional Studies Medicare Part C
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH